[1]Zolopa AR. The evolution of HIV treatment guidelines: current state-of-the art of ART. Antiviral Res. 2010, 85: 241244.

[2]José A. Estéa, Tomas Cihlarb. Current status and challenges of antiretroviral research and therapy. Antiviral Res, 2010, 85: 25-33

[3]Smith KY, Patel P, Fine D,et al. Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment. AIDS,2009, 23: 1547-1556.

[4]Lennox JL, DeJesus E, Lazzarin A, et al. Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: amulticentre, double-blind randomised controlled trial. Lancet, 2009, 374: 796 ,806.

[5]Paredes R, Clotet B. Clinical management of HIV-1 resistance. Antiviral Res, 2010, 85: 245,265.

[6]Hawkins T. Understanding and managing the adverse effects of antiretroviral therapy. Antiviral Res,2010, 85: 201209.

[7]Soriano V, Vispo E, Labarga P, et al. Viral hepatitis and HIV co-infection. Antiviral Res. 2010, 85: 303315

[8]Van Rompay KK. Evaluation of antiretrovirals in animal models of HIV infection. Antiviral Res.2010, 85: 159175.

[9]Chesney MA, Morin M, Sherr L. Adherence to HIV combination therapy. Social Sci. Med, 2000,50, 1599,1605.

[10]Osterberg L, Blaschke T. Adherence to medication. N. Engl. J. Med.2005, 353: 487,497.

[11]Martin J, Hitchcock MJ, De Clercq E, Prusoff W. Early nucleoside reverse transcriptase inhibitors for the treatment of HIV: a brief history of stavudine and its comparison with other dideoxynucleosides. Antiviral Res, 2010, 85: 34-38.

[12]Falutz J, Allas S, Blot K,et al. Metabolic effects of a growth hormone- releasing factor in patients with HIV. N. Engl. J. Med. 2007, 357: 2359,2370.

[13]Calmy A, Hirschel B, Cooper DA, Carr A. A new era of antiretroviral drug toxicity. Antivir Ther, 2009, 14: 165,179.

[14]Naeger LK, Struble KA, Murray JS, Birnkrant DB. Running a tightrope: regulatory challenges in the development of antiretrovirals. Antiviral Res, 2010, 85: 232,240.

[15]Cohen MS, Kaleebu P, Coates T. Prevention of the sexual transmission of HIV-1: preparing for success. J. Int. AIDS Soc. 2008, 11:4.

精品学习网 医药卫生栏目